Raleigh Coatings acquired by Advanced Medical Solutions in £22million deal
Raleigh Coatings has been acquired by Advanced Medical Solutions Group plc (AMS) in a £22million deal that will be a major boost for both companies.
As a surgical and advanced wound care specialist company, AMS is a perfect fit as a parent company for Raleigh Coatings and the businesses are looking forward to an exciting future together.
Raleigh is the only independent UK company that offers acrylic and silicone gel contract coating for the wound care market, and one of very few companies offering this specialism in the world. We provide tailor-made solutions for our blue-chip customer base, which includes many of the major wound care and specialist manufacturers in the healthcare sector.
We have a pipeline of innovative developments which will ensure our continued growth as a leading player in wound care and bio-diagnostics.
The acquisition strengthens AMS’s position in the wound care sector by enabling the company to bring specialist services such as acrylic and silicone coating, perforation processing and other capabilities which are currently outsourced, in-house.
Bringing new projects to the medical space
Already a key supplier to AMS, Raleigh’s expertise will allow AMS to enter the bio-diagnostic testing sector and help it to increase efficiency of wound care manufacturing operations and bring new projects to the medical market.
Chris Meredith, CEO of AMS, said: “We are delighted to add Raleigh to the Group. We have been looking for synergistic technologies that add value to our wound care business and this acquisition strengthens our position and product offering in that sector significantly.
“Having outsourced silicone coating and perforation for some time, we are pleased to bring this capability in-house. Raleigh has also played an important part in improving the design of our LiquiBand® XL mesh which we see as an important part of our continued US growth strategy. Raleigh’s expertise in other sectors, such as bio-diagnostic strips, also opens up further new commercial opportunities for the Group. We look forward to welcoming the Raleigh team to the Group to build on their commercial success and leverage their development pipeline.”
Julian Watkins, business development manager at Raleigh Coatings, said: “The acquisition of Raleigh Coatings by Advanced Medical Solutions from Apollo Chemicals Group Ltd, is great news for all concerned. It will enable us to continue with our innovative work, while providing enhanced product offerings and creating new opportunities for growth.
“No jobs are affected by the acquisition and we continue to operate from our recently upgraded manufacturing facility in Eccleshall. It will be business as usual for all of our clients, who we thank for their continued custom.
There are clear synergies between the two companies and we’re looking forward to working with AMS and going from strength to strength in our new partnership.”